BTG Pactual Asset Management US’s iShares Biotechnology ETF IBB Stock Holding History

BTG Pactual Asset Management US’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.7M	Buy	15,997 +21	+0.1%	+$3.59K	0.23%	96
2025 Q4	$2.02M	Sell	15,976 -578	-3%	-$93.9K	0.2%	86
2025 Q3	$2.09M	Buy	16,554 +928	+6%	+$127K	0.1%	77
2025 Q2	$1.98M	Buy	15,626 +433	+3%	+$53.2K	0.22%	89
2025 Q1	$1.94M	Buy	15,193 +1,749	+13%	+$237K	0.21%	108
2024 Q4	$1.52M	Sell	13,444 -344	-2%	-$48.4K	0.16%	124
2024 Q3	$1.56M	Buy	13,788 +1,517	+12%	+$219K	0.13%	132
2024 Q2	$1.68M	Buy	+12,271	New	+$1.64M	0.25%	77

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTG Pactual Asset Management US's IBB Position: Q1 2026 in Review

BTG Pactual Asset Management US increased its iShares Biotechnology ETF (IBB) stake by 0.13% in Q1 2026, buying an estimated $3.59K and bringing the position to 15,997 shares worth $2.7M. The position accounts for 0.23% of the portfolio, ranked #96.

BTG Pactual Asset Management US first reported a position in IBB in Q2 2024 and has held it in 8 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

BTG Pactual Asset Management US held 15,997 shares of iShares Biotechnology ETF worth $2.7M as of Q1 2026.
BTG Pactual Asset Management US bought 21 iShares Biotechnology ETF shares in Q1 2026, an estimated $3.59K.
iShares Biotechnology ETF made up 0.23% of BTG Pactual Asset Management US's portfolio in Q1 2026, its #96 holding.
BTG Pactual Asset Management US first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 8 quarters since.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q1 2026, filed 14 May 2026.